EYLEA: payments to doctors
Payments that named EYLEA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $12.3M
- Providers
- 5,690
- Transactions
- 36,711
- Average per transaction
- $334
The per-transaction average — $334 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,690 providers the average total is $2,156, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $10,411,316 | 84.9% |
| Regeneron | $1,858,563 | 15.1% |
| Bayer | $38 | 0.0% |